Hester Biosciences Share Price

₹ 2,300.00

+₹10.70 (0.47%)
1D
Last updated 02 Nov, 2026, 15:29 IST
NSE: HESTERBIO
|
Pharmaceuticals

Hester Biosciences Share Price Today

As of 2 Nov 2026, Hester Biosciences share price is ₹2,300.00. The stock opened at ₹2,374.00, compared to its previous close of ₹2,289.30. During today's trading session, Hester Biosciences share price moved in the range of ₹2,255.60 to ₹2,374.00, with an average price of ₹2,314.80 for the day. Looking at its last 52-week, the stock has touched a low of ₹1,239.30 and a high of ₹2,683.60. On the performance front, Hester Biosciences share price has increased by 39.44% over the last six months and is up 42.13% on a year-on-year basis.

Share price over the last 1 day fell from 2374.00 to 2300.00, ranging between 2257.00 and 2374.00.
₹2,255.60
0.47% up today
₹2,374.00
1D LOW
1D HIGH

Hester Biosciences Stock Insights

Latest Earning
Op Profit TrendUp by 305.26% QoQ
Latest Earning
Net Profit TrendUp by 484.47% QoQ
Latest Earning
Revenue TrendUp by 8.65% YoY
Stock Performance
OutperformingBeat Nifty by 3.31 % in last 1 month
Shareholding Pattern
PromoterPromoter decreased stake by 17.59%
Shareholding Pattern
FIIFII decreased stake by 2.74%
Hester Biosciences stock performance
Open₹2,374.00
High₹2,374.00
Low₹2,255.60
Prev. close₹2,289.30
Hester Biosciences trading activity
Volume1,267
Average traded price₹2,291.26
Last traded time03:29:57 02 Nov
Last traded quantity5
Circuit
L
H
₹1,831.50
₹2,747.10
52-week
L
H
₹1,239.30
₹2,683.60
Mkt Cap Cr
1,956.41
P/E
14.29
P/B
5.43
ROA
20.2%
ROE
15.45%
ROCE
14.34%
Quick Ratio
0.89
EV/EBITDA
11.16

Based on fundamentals, this stock's

Performance: 5 out of 5, Excellent
Performance
Excellent
Hester Bios outperforming all market indices
Valuation: 1 out of 5, Overvalued
Valuation
Overvalued
Hester Bios appears overvalued compared to its peers
Earnings: 5 out of 5, Excellent
Earnings
Excellent
Hester Bios revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,26,661.7438.834.789.61%13.79%18.65%2.3122.27
Divis Laboratories2,57,902.7388.1715.3914.6%15.32%19.56%3.558.97
Torrent Pharmaceuticals1,76,306.2184.09.64.7%11.42%11.37%0.7533.6
Laurus Labs1,29,242.6897.021.3311.58%22.11%20.91%0.6854.77
Zydus Lifesciences1,24,089.4827.024.588.57%18.59%17.35%0.9116.42
Dr. Reddy's Laboratories1,12,698.5340.842.94.79%7.21%8.58%1.3519.05
Cipla1,11,486.1439.063.156.6%8.18%10.8%2.521.03
Mankind Pharma1,02,796.6045.425.857.82%12.76%14.68%0.7425.01
Aurobindo Pharma96,536.9026.022.556.34%9.25%11.76%1.1512.38
Lupin91,870.1616.554.0914.47%23.76%24.88%1.429.83

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

Hester Biosciences Company Background

ISIN
INE782E01017
Sector Market Cap
₹ 1,956.41 Cr

Hester Biosciences Limited is an India-based animal healthcare company. The Company is principally engaged in manufacturing poultry vaccines, large animal vaccines, and trading poultry, large animal, and petcare health products. It operates through three segments: Poultry Healthcare, Animal Healthcare, and Petcare. The Poultry Healthcare vaccines include Gumboro I, Inactivated Chick ND, Inactivated Coryza, Inactivated EDS, Inactivated FC3, Inactivated FC4, Inactivated IB, and Inactivated IBD. The Animal Healthcare vaccines include Goat Pox Vaccine, Live Brucella, PPR Vaccine - Nigerian 75/1, and PPR Vaccine - Sungri/96. Its Petcare products include Cefshot Tazo Injection, Hestacef CV, Hestacef DS, Pawfresh, Synoton, Petsglow, and Vitacoat. The Company also operates diagnostic labs for poultry and provides diagnostic kits for sero-surveillance and mastitis prevention for cattle farms. Its manufacturing facility is located at Meda Adraj Village, Mehsana District, Gujarat.

Hester Biosciences Financial Highlights

  • Revenue: Hester Biosciences reported revenue of ₹342.28 crore in FY26 vs ₹315.02 crore in FY25. It showed an increase of 8.65% on a yearly basis.
  • Operating Profit: Hester Biosciences reported an operating profit of ₹75.84 crore in FY26 vs ₹39.57 crore in FY25. It showed an increase of 91.66% on a year-on-year basis.
  • Net Profit: Hester Biosciences reported a net profit of ₹57.48 crore in FY26 vs ₹28.83 crore in FY25. It showed an increase of 99.38% on a yearly basis.

Hester Biosciences Quarterly Result Highlights

  • Hester Biosciences reported revenue of ₹78.88 crore in Jun 2026, compared with ₹97.08 crore in Mar 2026, representing a decrease of 18.75% on a quarter-on-quarter (QoQ) basis.
  • Hester Biosciences reported an operating profit of ₹101.68 crore in Jun 2026, compared with ₹25.09 crore in Mar 2026, representing an increase of 305.26% on a quarter-on-quarter (QoQ) basis.
  • Hester Biosciences reported a profit of ₹96.73 crore in Jun 2026, compared with ₹16.55 crore in Mar 2026, reflecting an increase of 484.47% on a QoQ basis.
  • The earnings per share (EPS) of Hester Biosciences stood at ₹67.57 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
44.28%
FII
0.31%
Other DII
0.08%
Retail and other
55.33%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Dec 20250.51%
Mar 20260.38%
Jun 20260.31%
Sep 20260.31%

Hester Biosciences Investment Returns

1 day
-0.46%
1 week
+10.72%
1 month
+7.14%
1 year
+42.13%
3 years
+38.16%
5 years
-5.30%

Hester Biosciences Share Price History

Hester Biosciences share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
30 Oct 26
₹2,258.50 / ₹2,289.30
-0.79%
29 Oct 26
₹2,243.70 / ₹2,307.60
+2.85%
28 Oct 26
₹2,163.80 / ₹2,243.70
+4.22%
27 Oct 26
₹2,020.50 / ₹2,152.90
+4.61%
Show more

Hester Biosciences Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹332.60₹311.10₹304.55₹266.09
Other Income₹9.68₹3.92₹10.64₹15.15
Total Revenue₹342.28₹315.03₹315.18₹281.24
Total Expenses₹275.76₹279.56₹287.84₹245.50
Profit Before Tax₹75.84₹39.57₹31.95₹40.15
Tax₹18.35₹10.75₹10.79₹12.12
Profit After Tax₹57.48₹28.83₹21.17₹28.04
EPS - Basic₹67.57₹33.89₹24.88₹31.30
EPS - Diluted₹67.57₹33.89₹24.88₹31.30

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹75.84₹39.57₹31.95₹40.15
Income before WC changes₹109.41₹66.04₹56.18₹52.54
Change in Assets-₹31.40₹8.34₹13.06-₹42.13
Change in Liabilities₹0.26₹1.60-₹9.38₹21.29
Change in WC-₹31.15₹9.95₹3.67-₹20.84
Cash flow from Operations₹64.14₹64.51₹48.18₹23.60
Cash flow from Investing-₹2.87-₹19.00-₹22.61-₹77.00
Cash flow from Financing-₹48.79-₹51.72-₹26.09₹41.76
Total Cash Flow-₹2.82-₹6.72-₹0.36-₹11.59
Cash (Start of the year)₹5.59₹12.31₹12.67₹24.75
Cash (End of the year)₹2.77₹5.59₹12.31₹13.16

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹469.38₹458.21₹447.73₹442.37
Current Assets₹208.56₹195.17₹214.62₹227.59
Total Assets₹677.94₹653.39₹662.35₹669.97
Current Liabilities₹152.48₹125.18₹105.47₹148.70
Net Current Asset₹56.08₹69.99₹109.14₹78.90
Non-Current Liabilities₹157.67₹201.55₹254.00₹232.72
Equity Capital₹367.79₹326.66₹302.88₹288.55
Total Equity & Liabilities₹677.94₹653.39₹662.35₹669.97

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹292.14₹286.47₹285.16₹254.00
Other Income₹7.64₹4.76₹4.26₹5.32
Total Revenue₹299.77₹291.23₹289.42₹259.32
Total Expenses₹237.09₹249.47₹252.69₹215.40
Profit Before Tax₹69.68₹41.76₹36.73₹43.92
Tax₹17.58₹9.92₹9.57₹11.58
Profit After Tax₹52.10₹31.84₹27.16₹32.34
EPS - Basic₹61.24₹37.43₹31.93₹38.02
EPS - Diluted₹61.24₹37.43₹31.93₹38.02

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹69.68₹41.76₹36.73₹43.92
Income before WC changes₹81.91₹57.58₹50.06₹58.48
Change in Assets-₹10.86₹13.04₹10.16-₹44.32
Change in Liabilities-₹6.64₹3.27-₹6.33₹27.27
Change in WC-₹17.50₹16.31₹3.84-₹17.05
Cash flow from Operations₹50.92₹63.97₹42.86₹33.36
Cash flow from Investing-₹2.36-₹19.04-₹20.59-₹71.96
Cash flow from Financing-₹48.31-₹46.35-₹24.12₹41.38
Total Cash Flow₹0.25-₹1.42-₹1.85₹2.77
Cash (Start of the year)₹0.55₹1.97₹3.81₹1.53
Cash (End of the year)₹0.79₹0.55₹1.97₹4.30

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹367.58₹360.76₹345.13₹329.77
Current Assets₹189.76₹185.24₹204.41₹216.05
Total Assets₹557.35₹546.00₹549.55₹545.82
Current Liabilities₹91.92₹96.70₹97.72₹136.47
Net Current Asset₹97.85₹88.53₹106.69₹79.58
Non-Current Liabilities₹80.25₹110.21₹139.11₹116.96
Equity Capital₹385.18₹339.09₹312.71₹292.38
Total Equity & Liabilities₹557.35₹546.00₹549.55₹545.82
* All values are in INR Crore
Hester Biosciences market depth
Bid quantityBid priceAsk priceAsk quantity
0000
0000
0000
0000
0000
Total bid quantity0
Total ask quantity0
Hester Biosciences technical summary
Bearish indicators4
Neutral indicators3
Bullish indicators1
OverallSlightly Bearish
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict
RSI (14)
57.94
Neutral
ATR (14)
97.39
Neutral
STOCH(9,6)
86.46
Bearish
STOCH RSI (14)
91.89
Bearish
ADX(9)
20.58
Bearish
UO(9)
56.25
Neutral
ROC(12)
7.63
Bullish
WillR(14)
-13.54
Bearish
Period
Simple value
Exponential vaue
5D
2210.32
2238.03
10D
2192.85
2203.54
20D
2160.37
2188.52
50D
2224.53
2209.1
100D
2259.72
2163.27
Volume trend — traded volume by day
2 Nov0L
30 Oct0L
29 Oct0L
28 Oct0L
27 Oct0L
26 Oct0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

Hester Biosciences
Pharmaceuticals
Add Stock
Add Another

Hester Biosciences Returns Calculator

Ex-date: 14 Jul 2026

Top Gainers

ITI Share Price
₹259.14
+43.19 (+20%)
ENGINERSIN Share Price
₹289.65
+37.8 (+15.01%)
AFFLE Share Price
₹1506.50
+164.7 (+12.27%)
PRAJIND Share Price
₹271.13
+29.43 (+12.18%)
DIXON Share Price
₹12319.00
+1319 (+11.99%)
See more

Top Losers

INDIGOPNTS Share Price
₹870.00
-127.3 (-12.76%)
CLEAN Share Price
₹662.60
-53 (-7.41%)
ZEEL Share Price
₹61.58
-4.82 (-7.26%)
SYRMA Share Price
₹1512.00
-113.3 (-6.97%)
POLICYBZR Share Price
₹931.00
-69.1 (-6.91%)
See more

Hester Biosciences Share Price FAQs

Please be aware that Hester Biosciences stock prices are subject to continuous fluctuations due to various factors.